Report and summary of the major conclusions from Statistics in Genotoxicity Testing Working Group from the International Workshop on Genotoxicity Test Procedures (IWGTP), March 1999

Author(s):  
D. P. Lovell ◽  
I. Yoshimura ◽  
L. A. Hothorn ◽  
B. H. Margolin ◽  
K. Soper
Author(s):  
Elmar Gocke ◽  
Lutz M�ller ◽  
Peggy J. Guzzie ◽  
Susanne Brendler-Schwaab ◽  
Steven Bulera ◽  
...  

Author(s):  
D.J. Kirkland ◽  
M. Hayashi ◽  
J. T. MacGregor ◽  
L. M�ller ◽  
L. Schechtman ◽  
...  

Author(s):  
Anthony M. Lynch ◽  
Peggy J. Guzzie ◽  
Daniel Bauer ◽  
Elmar Gocke ◽  
Satoru Itoh ◽  
...  

1990 ◽  
Vol 18 (1_part_1) ◽  
pp. 339-344 ◽  
Author(s):  
Michael Balls ◽  
Philip Botham ◽  
André Cordier ◽  
Silvano Fumero ◽  
Detlef Kayser ◽  
...  

Blood ◽  
2008 ◽  
Vol 111 (12) ◽  
pp. 5446-5456 ◽  
Author(s):  
Michael Hallek ◽  
Bruce D. Cheson ◽  
Daniel Catovsky ◽  
Federico Caligaris-Cappio ◽  
Guillaume Dighiero ◽  
...  

Abstract Standardized criteria for diagnosis and response assessment are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies. Therefore, a National Cancer Institute–sponsored Working Group (NCI-WG) on chronic lymphocytic leukemia (CLL) published guidelines for the design and conduct of clinical trials for patients with CLL in 1988, which were updated in 1996. During the past decade, considerable progress has been achieved in defining new prognostic markers, diagnostic parameters, and treatment options. This prompted the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) to provide updated recommendations for the management of CLL in clinical trials and general practice.


Sign in / Sign up

Export Citation Format

Share Document